OBJECTIVES: To determine the safety and acute tolerance of performing prostate @entity1168 ( @entity1168 ) brachytherapy in a free-standing @entity5 center setting, and to report our approach in delivering such treatment. METHODS: @entity1 treated with prostate @entity1168 from the inception of our program through December 2004 were included. Disease- and treatment-related information was gathered from chart review. Acute side effects were obtained from both chart review and questioning the @entity1 at follow-up visits. RESULTS: A total of 234 @entity1 were treated with 459 @entity1168 needle insertions. Nearly all @entity1 were treated with external beam irradiation, and the majority also received adjuvant hormonal manipulation. There were no adverse events related to transport to the free-standing @entity5 center. Treatment was well tolerated, with only 3.7% of procedures developing retention requiring catheter placement; 20% of @entity1 reported significant postimplant @entity3833 , mean duration of any @entity3833 being 7.5 days. Postimplant retention and length of any @entity3833 were not found to be related to any of the analyzed factors. Severity of @entity3833 was found to be related only to timing of external beam. Postimplant retention was more frequent for some physicians, but this finding was not statistically significant. CONCLUSIONS: Prostate @entity1168 brachytherapy can be delivered safely and effectively in an ambulatory free-standing @entity5 center setting when done by a urology and radiation oncology team working in close conjunction. Treatment combining @entity1168 brachytherapy as described with external beam radiation, with or without @entity342 manipulation, is well tolerated by the @entity1 .

Prostate XXXX brachytherapy in a free-standing @entity5 center setting.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cancer'] @entity3833 :: ('MESH:D053159', 'Disease') :: ['dysuria'] @entity342 :: ('CHEBI:50113', 'Chemical') :: ['androgen'] @entity1168 :: ('MESH:D001919', 'Disease') :: ['HDR', 'high dose rate']
@entity1168 :: (MESH:D001919,Disease) :: ['high dose rate']
